Vonicog alfa for the management of von Willebrand disease: a comprehensive review and single-center experience

This article comprehensively reviews the efficacy, safety, pharmacokinetics, and pharmacodynamics of vonicog alfa. These points will be discussed using institutional experiential data from the University of Virginia (UVA) Health System in relation to the clinical studies. The goal of this review article is to offer insights to clinical directions, discuss operational challenges, and offer guidance for future studies and formulary decisions.
Source: Journal of Thrombosis and Thrombolysis - Category: Hematology Source Type: research